Continuous Glucose Monitoring – clinical trial quality data
As we have espoused here on Diabettech in the past, not all clinical trials for CGM systems are equal. To this, end, we’re now proud […]
As we have espoused here on Diabettech in the past, not all clinical trials for CGM systems are equal. To this, end, we’re now proud […]
What impact does a botched rollout of an app update have on a CGM provider?
Trying out a smartwatch with non-invasive glucose monitoring. This isnt the watch you’re looking for….
You may remember, back in the summer of 2022, the author of this site wore an Aidex system (distributed by GlucoRX in the UK) to […]
As many will have seen, the Dexcom G7 never had, and recently the G6, has removed back-smoothing from the apps on the phone, for various […]
Having tested a G7 against the Libre3, and found that without calibration, it tended to produce results that I wasn’t satisfied with using just the […]
As previously discussed in this article, I have been wearing the Libre 3, Dexcom G6 and G7, to compare performance across all three. These are […]
As I’m currently testing a Libre3, and have taken a look back at the various accuracy studies as a part of this to review MARD data, […]
It’s finally here. The Dexcom G7 has landed. And now it’s time for us here at Diabettech to pitch it against Abbott’s Freestyle Libre 3. […]
Taking a look at the reasons why Dexcom One may force Abbott to make Libre2 a true real time CGM.
Copyright © 2024 | WordPress Theme by MH Themes